Neuronal death is the main cause of nerve function impairment after spinal cord injury (SCI). Exosome-based therapy has become a novel strategy for tissue injury repair. We designed a method to treat SCI using exosomes secreted by adipose tissue–derived stromal cells (ADSCs) under hypoxic conditions. We established a neuronal oxygen-glucose deprivation and reperfusion (OGD/R) model in vitro to simulate the hypoxic environment after SCI. We observed that exosomes derived from hypoxia-conditioned ADSCs (Hypo-exo) significantly reduced neuronal apoptosis after OGD. By establishing a rat SCI model, we found that Hypo-exo can significantly reduce the formation of cavities in the injured area and improve the functional recovery of the hindlimbs of rats after injury. To explore the molecular mechanism, we conducted microRNA sequencing analysis of exosomes. Through real-time polymerase chain reaction, dual luciferase reporter assays and signaling pathway chip analysis, we determined that miR-499a-5p regulates the JNK3/c-jun-apoptotic signaling pathway by targeting JNK3. Further, we verified the expression of the key proteins in the JNK3/c-jun-apoptotic signaling pathway by immunofluorescence and Western blotting. These results support the hypothesis that Hypo-exo can reduce neuronal apoptosis after SCI and may provide new methods to treat SCI.
Get full access to this article
View all access options for this article.
References
1.
LiangY., LiM., LuT., PengW., and WuJ.H. (2017). Andrographolide promotes neural differentiation of rat adipose tissue-derived stromal cells through Wnt/β-catenin signaling pathway. Biomed. Res. Int. 2017, 4210867.
2.
WuJ.H., LiM., LiangY., LuT., and DuanC.Y. (2016). Migration of adipose-derived mesenchymal stem cells stably expressing chondroitinase ABC in vitro. Chin. Med. J. 129, 1592–1599.
BucanV., VaslaitisD., PeckC.T., StraussS., VogtP.M., and RadtkeC. (2018). Effect of exosomes from rat adipose-derived mesenchymal stem cells on neurite outgrowth and sciatic nerve regeneration after crush injury. Mol. Neurobiol. 56, 1812–1824.
5.
YunC.W., and LeeS.H. (2019). Potential and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for acute/chronic kidney disease. Int. J. Mol. Sci. 20.
6.
TkachM., and ThéryC. (2016). Communication by extracellular vesicles: where we are and where we need to go. Cell, 164, 1226–1232.
7.
HuY., RaoS.S., WangZ.X., CaoJ., TanY.J., LuoJ., LiH.M., ZhangW.S., ChenC.Y., and XieH. (2018). Exosomes from human umbilical cord blood accelerate cutaneous wound healing through miR-21-3p-mediated promotion of angiogenesis and fibroblast function. Theranostics, 8, 169–184.
8.
KalluriR., and LeBleuV.S. (2020). The biology, function, and biomedical applications of exosomes. Science. 367.
9.
PegtelD.M., and GouldS.J. (2019). Exosomes. Ann. Rev. Biochem. 88, 487–514.
10.
MaziniL., RochetteL., AdmouB., AmalS., and MalkaG. (2020). Hopes and limits of adipose-derived stem cells (ADSCs) and Mesenchymal stem cells (MSCs) in wound healing. Int. J. Mol. Sci. 21.
11.
ShiueS.J., RauR.H., ShiueH.S., HungY.W., LiZ.X., YangK.D., and ChengJ.-K. (2019). Mesenchymal stem cell exosomes as a cell-free therapy for nerve injury–induced pain in rats. Pain, 160, 210–223.
12.
MathiyalaganP., LiangY., KimD., MisenerS., ThorneT., KamideC.E., KlyachkoE., LosordoD.W., HajjarR.J., and SahooS. (2017). Angiogenic mechanisms of human CD34(+) stem cell exosomes in the repair of ischemic hindlimb. Circ. Res. 120, 1466–1476.
13.
RosováI., DaoM., CapocciaB., LinkD., and NoltaJ.A. (2008). Hypoxic preconditioning results in increased motility and improved therapeutic potential of human mesenchymal stem cells. Stem Cells, 26, 2173–2182.
IngatoD., LeeJ.U., SimS.J., and KwonY.J. (2016). Good things come in small packages: Overcoming challenges to harness extracellular vesicles for therapeutic delivery. J Control Release, 241, 174–185.
16.
TangJ., HuZ., TanJ., YangS., and ZengL. (2016). Parkin protects against oxygen-glucose deprivation/reperfusion insult by promoting Drp1 degradation. Oxid. Med. Cell Longev. 2016, 8474303.
17.
LobbR.J., BeckerM., WenS.W., WongC.S., WiegmansA.P., LeimgruberA., and MöllerA. (2015). Optimized exosome isolation protocol for cell culture supernatant and human plasma. J. Extracell. Vesicles, 4, 27031.
18.
BassoD.M., BeattieM.S., and BresnahanJ.C. (1995). A sensitive and reliable locomotor rating scale for open field testing in rats. J. Neurotrauma, 12, 1–21.
19.
SolomonL.A., RussellB.A., WatsonL.A., BeierF., and BérubéN.G. (2013). Targeted loss of the ATR-X syndrome protein in the limb mesenchyme of mice causes brachydactyly. Hum. Mol. Genet. 22, 5015–5025.
20.
TomasoniS., LongarettiL., RotaC., MorigiM., ContiS., GottiE., CapelliC., IntronaM., RemuzziG., and BenigniA. (2013). Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev. 22, 772–780.
LuarteA., BátizL.F., WynekenU., and LafourcadeC. (2016). Potential therapies by stem cell-derived exosomes in CNS diseases: focusing on the neurogenic niche. Stem Cells Int. 2016, 5736059.
23.
HuangJ.H., YinX.M., XuY., XuC.C., LinX., YeF.B., CaoY., and LinF.Y. (2017). Systemic administration of exosomes released from mesenchymal stromal cells attenuates apoptosis, inflammation, and promotes angiogenesis after spinal cord injury in rats. J. Neurotrauma, 34, 3388–3396.
24.
BaiL., ShaoH., WangH., ZhangZ., SuC., DongL., YuB., ChenX., LiX., and ZhangX. (2017). Effects of mesenchymal stem cell-derived exosomes on experimental autoimmune uveitis. Sci. Rep. 7, 4323.
25.
HuX., WuR., ShehadehL.A., ZhouQ., JiangC., HuangX., ZhangL., GaoF., LiuX., YuH., WebsterK.A., and WangJ. (2014). Severe hypoxia exerts parallel and cell-specific regulation of gene expression and alternative splicing in human mesenchymal stem cells. BMC Genomics, 15, 303.
26.
FanJ., ZhangZ., ChaoX., GuJ., CaiW., ZhouW., YinG., and LiQ. (2014). Ischemic preconditioning enhances autophagy but suppresses autophagic cell death in rat spinal neurons following ischemia-reperfusion. Brain Res. 1562, 76–86.
27.
LiuW., RongY., WangJ., ZhouZ., GeX., JiC., JiangD., GongF., LiL., ChenJ., ZhaoS., KongF., GuC., FanJ., and CaiW. (2020). Exosome-shuttled miR-216a-5p from hypoxic preconditioned mesenchymal stem cells repair traumatic spinal cord injury by shifting microglial M1/M2 polarization. J. Neuroinflammation, 17, 47.
28.
XiaoC., WangK., XuY., HuH., ZhangN., WangY., ZhongZ., ZhaoJ., LiQ., ZhuD., KeC., ZhongS., WuX., YuH., ZhuW., ChenJ., ZhangJ., WangJ., and HuX. (2018). Transplanted mesenchymal stem cells reduce autophagic flux in infarcted hearts via the exosomal transfer of miR-125b. Circ. Res. 123, 564–578.
29.
WangC., ZhuG., HeW., YinH., LinF., GouX., and LiX. (2019). BMSCs protect against renal ischemia-reperfusion injury by secreting exosomes loaded with miR-199a-5p that target BIP to inhibit endoplasmic reticulum stress at the very early reperfusion stages. FASEB J. 33, 5440–5456.
ChoiB.Y., ChoiH.S., KoK., ChoY.Y., ZhuF., KangB.S., ErmakovaS.P., MaW.Y., BodeA.M., and DongZ. (2005). The tumor suppressor p16(INK4a) prevents cell transformation through inhibition of c-Jun phosphorylation and AP-1 activity. Nat. Struct. Mol. Biol. 12, 699–707.
32.
AtochinD.N., SchepetkinI.A., KhlebnikovA.I., SeledtsovV.I., SwansonH., QuinnM.T., and HuangP.L. (2016). A novel dual NO-donating oxime and c-Jun N-terminal kinase inhibitor protects against cerebral ischemia-reperfusion injury in mice. Neurosci. Lett. 618, 45–49.
33.
LiL., and LuoZ. (2017). Dysregulated miR-27a-3p promotes nasopharyngeal carcinoma cell proliferation and migration by targeting Mapk10. Oncol. Rep. 37, 2679–2687.
34.
AngelP., SzabowskiA., and Schorpp-KistnerM. (2001). Function and regulation of AP-1 subunits in skin physiology and pathology. Oncogene, 20, 2413–2423.
35.
ShaulianE., and KarinM. (2001). AP-1 in cell proliferation and survival. Oncogene, 20, 2390–2400.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
